By Jacqueline K. Olive, Peter J. Hotez, Ashish Damania, Melissa S. Nolan Summary Points A social movement of public health vaccine opposition has been growing in the United States in recent years; [Read more]
Characterized by the World Health Organization as a “neglected tropical disease,” leprosy (also known as Hansen’s disease) is caused by Mycobacterium leprae. Nearly a quarter of a million people are diagnosed with [Read more]
Unprecedented levels of immunosuppression in countries like Australia and the US must be considered in planning for the risk of smallpox re-emerging in the world, an expert in infectious diseases from the [Read more]
Malaria is ranked by the Department of Defense as the number one infectious disease threat to military personnel deployed to areas where malaria is endemic. This includes countries spanning the tropical and [Read more]
The U.S. Centers for Disease Control and Prevention is seeking a vendor who can obtain anonymous pre- and post-immunization sera from specified age-groups of Europeans. The study must be conducted in a [Read more]
AbCellera Biologics Inc. this week announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks. Under DARPA’s Pandemic Prevention Platform (P3) [Read more]
To enable a rapid vaccine response during a severe outbreak or pandemic, there is a pressing need for a potency test that is rapid and has sufficient sensitivity to track potency in [Read more]
The Defense Advanced Research Projects Agency (DARPA) launched the Pandemic Prevention Platform (P3) program in 2017, with the eventual goal of halting the spread of any infectious disease outbreak before it can escalate into a pandemic. [Read more]
The National Opinion Research Center at the University of Chicago has been awarded a contract in support of the National Center for Immunizations and Respiratory Diseases (NCIRD) Influenza Division of the Centers [Read more]
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2018-2019 flu season. Approximately 3.6 million doses are included in this requirement. The vaccines shall [Read more]
© 2019 STEMAR MEDIA